Hossein A. Hamed, Ph.D.
Affiliations: | 2012 | Biochemistry | Virginia Commonwealth University, Richmond, VA, United States |
Area:
Biochemistry, Cell BiologyGoogle:
"Hossein Hamed"Mean distance: (not calculated yet)
Parents
Sign in to add mentor
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Monks A, Zhao Y, Hose C, et al. (2018) The NCI Transcriptional Pharmacodynamics Workbench: a tool to examine dynamic expression profiling of therapeutic response in the NCI-60 cell line panel. Cancer Research |
| Zhang G, Park MA, Mitchell C, et al. (2016) Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling. The Journal of Biological Chemistry. 291: 20823 |
| Tavallai M, Hamed HA, Roberts JL, et al. (2015) Nexavar/Stivarga and viagra interact to kill tumor cells. Journal of Cellular Physiology. 230: 2281-98 |
| Hamed HA, Tavallai S, Grant S, et al. (2015) Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells. Journal of Cellular Physiology. 230: 131-9 |
| Tavallai S, Hamed HA, Grant S, et al. (2014) Pazopanib and HDAC inhibitors interact to kill sarcoma cells. Cancer Biology & Therapy. 15: 578-85 |
| Bhatia S, Emdad L, Das SK, et al. (2014) Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials. Expert Opinion On Investigational Drugs. 23: 489-500 |
| Booth LA, Tavallai S, Hamed HA, et al. (2014) The role of cell signalling in the crosstalk between autophagy and apoptosis. Cellular Signalling. 26: 549-55 |
| Cruickshanks NA, Hamed HA, Booth LA, et al. (2014) Abstract 796: Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy Cancer Research. 74: 796-796 |
| Booth LA, Cruickshanks NA, Sajithlal GB, et al. (2014) Abstract 2690: Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells Cancer Research. 74: 2690-2690 |
| Hamed HA, Das SK, Sokhi UK, et al. (2013) Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells. Cancer Biology & Therapy. 14: 1039-49 |